Video

Enfortumab Vedotin (EV) Monotherapy and Pembrolizumab (P) Combination Treatments in Urothelial Cancer

Arlene Siefker-Radtke, MD, opens a discussion recapping the ESMO 2022 conference surrounding advanced and metastatic urothelial cancer.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Related Videos
      4 experts are featured in this series.
      Understanding the Hesitancy to Prescribe Amyloid-Targeting Therapies for Patients With Alzheimer Disease
      The Metro Nashville Public Schools Initiative
      The Metro Nashville Public Schools Initiative
      5 experts are featured in this series
      Recurrence Rates in Uncomplicated UTIs
      4 experts are featured in this series.
      Patient Selection for Amyloid-Targeting Therapies: Key Characteristics and Considerations
      Adoption Strategies
      Adoption Strategies
      5 experts are featured in this series
      Patient Factors Influencing Antibiotic Selection in Uncomplicated UTIs
      Dr Johnie Rose
      Mixed Outcomes Persist Between MA, FFS Beneficiaries: Johnie Rose, MD, PhD
      AJMC Q&A with Jason Bellet, Dr Geoffrey Rutledge, and Dan Nardi
      Experts Push to Preserve Telehealth, Payment Parity Post Pandemic
      Andrew Evens, DO
      Limited Clinical Insight Poses Barrier to Optimal NHL Treatment: Andrew Evens, DO
      AJMC Q&A with Jason Bellet, Dr Geoffrey Rutledge, and Dan Nardi
      Experts Address Health Care Gaps Exposed by COVID-19 Pandemic
      Related Content
      MASLD significantly increases the risk of severe infection, a literature review suggests. | Image credit: SewcreamStudio - stock.adobe.com
      April 12th 2025

      MASLD Associated With 2-Fold Increase of Serious Bacterial Infection

      AJMC Contributor
      Data from a meta-analysis of 8 observational studies accounting for more than 26 million people across the globe were evaluated in a new review.
      managed care cast logo
      December 23rd 2024

      Five Years Later: Ongoing COVID-19 Challenges, Next Steps

      Brooke McCormick
      On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
      None of the eteplirsen-treated patients reached an LVEF below 50%, compared with 22.1% of patients in the control group. | Image credit: inthasone - stock.adobe.com
      April 11th 2025

      Eteplirsen Treatment Linked to Slower Cardiac Decline in DMD

      Rose McNulty
      None of the eteplirsen-treated patients reached a left ventricular ejection fraction below 50% compared with 22.1% of patients in the control group.
      Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
      December 17th 2024

      Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

      Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
      Human brain illustration | Image Credit: Siarhei - stock.adobe.com
      April 10th 2025

      Inflammatory Diets Raise Risk of Brain Disorders

      Brooke McCormick
      Vegetables, fish oil, fruit, and high-fiber foods have anti-inflammatory effects, while low-fiber bread and animal fats are associated with pro-inflammatory effects. Diets heavier on these pro-inflammatory foods may be associated with higher risks of brain disorders.
      Novartis worker | Image credit: Novartis
      April 10th 2025

      Will the Coming Radiopharmaceutical Wave Reach More Patients With Cancer?

      Mary Caffrey
      This article appears in the April issue of Evidence-Based Oncology.

      2 Commerce Drive
      Suite 100
      Cranbury, NJ 08512

      © 2025 MJH Life Sciences® and AJMC®.
      All rights reserved.

      About
      Contact
      Editorial Boards
      Advertise
      Do Not Sell My Information
      Terms & Conditions
      Privacy Policy
      AJMC Managed Markets Network Logo
      CH LogoCenter for Biosimilars Logo